Belgian consensus on recommendations for standards of care for women with epilepsy before, during and after pregnancy

Acta Neurologica Belgica

Volumn 104, Issue 1, 2004, Pages 6-12

  Boon, Paul ^a   Hauman, Henri ^b   Legros, Benjamin ^c   Sadzot, Bernard ^f   van Rijckevorsel, Kenou ^d   van Zandycke, Michel ^e  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Algemeen Ziekenhuis Sint Maarten   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e General Hospital St Jan   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anti epileptic drugs; Epilepsy; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; ASCORBIC ACID; BENZODIAZEPINE DERIVATIVE; CALCIUM; CYANOCOBALAMIN; CYTOCHROME P450 3A4; ESTRADIOL; ESTROGEN; ETIRACETAM; FELBAMATE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; LEVONORGESTREL; MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROGESTERONE; SELENIUM; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; VITAMIN D; VITAMIN K GROUP; ZINC;

ARTICLE; BELGIUM; COUNSELING; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG INHIBITION; DRUG METABOLISM; DRUG MONITORING; EPILEPSY; FAMILY PLANNING; FETUS MALFORMATION; FETUS RISK; FOLLOW UP; HUMAN; MATERNAL CARE; ORAL CONTRACEPTION; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PROFESSIONAL STANDARDS REVIEW ORGANIZATION; SIDE EFFECT; VITAMIN SUPPLEMENTATION;

EID: 2342439978     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Anonymous. Randomised study of antiepileptic drug withdrawal in patients in remission. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Lancet, 1991, 337 (8751) : 1175-80.
2. Anonymous. Practice parameter : management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 1998, 51 (4) : 944-948.
3. Annegers J., Hauser W., Elveback L. Remission of seizures and relapse in patients with epilepsy. Epilepsia, 1979, 20 (6) : 729-37.
4. Barrett C., Richens A. Epilepsy and pregnancy : Report of an Epilepsy Research Foundation Workshop. Epilepsy Res., 2003, 52 (3) : 147-87.
5. Biale Y., Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet. Gynecol. Reprod. Biol., 1984, 18 (4) : 211-6.
6. Center for Disease Control and Prevention. Recommandations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly. Rep., 1992, 41 (RR-14) : 1-7.
7. Cornelissen M., Steegers-Theunissen R., Kollee L., Eskes T., Motohara K., Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am. J. Obstet. Gynecol., 1993, 168 (3 Pt 1) : 884-8.
8. Craig J., Morrison P., Morrow J., Patterson V. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate. Seizure, 1999, 8 (4) : 253-4.
9. Crawford P. Epilepsy and pregnancy. Seizure, 2002, 11 Suppl A : 212-9.
10. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs, 2002, 16 (4) : 263-72.
11. Crawford P., Appleton R., Betts T., Duncan J., Guthrie E., Morrow J. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure, 1999, 8 (4) : 201-17.
12. Dansky, et al. Maternal epilepsy and congenital malformations : correlation with maternal plasma anticonvulsant levels during pregnancy. In : Epilepsy, pregnancy and the child. Janz D. (ed.). New York, Raven Press, 1982 : 251-8.
13. Dansky L., et al. Plasma levels of phenytoin during pregnancy & the puerperium. In : Epilepsy, pregnancy and the child. Janz D. (ed.). New York, Raven Press, 1982 : 155-162.
14. Delgado-Escueta A., Janz D. Consensus guidelines : preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology, 1992, 42 (4) : 149-160.
15. Duncan S., Mercho S., Lopes-Cendes I., Seni M., Benjamin A., Dubeau F., Andermann F., Andermann E. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia, 2001, 42 (6) : 750-3.
16. Fairgrieve S. D., Jackson M., Jonas P., Walshaw D., White K., Montgomery T. L., Burn J., Lynch S. A. Population based, prospective study of the care of women with epilepsy in pregnancy. Brit. Med. J., 2000, 321 (7262) : 674-675.
17. Finnell R., Nau H., Yerby M. Teratogenicity of antiepileptic drugs. In : Antiepileptic drugs. Levy R., Mattson R. (ed.). New York, Raven Press, 1995, 4 : 209-240.
18. Gaily E., Kantola-Sorsa E., Granstrom M. L. Specific cognitive dysfunction in children with epileptic mothers. Dev. Med. Child. Neurol., 1990, 32 (5) : 403-14.
19. Granstrom M. L., Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology, 1992, 42 (4 Suppl 5) : 144-8.
20. Guberman A. Hormonal contraception and epilepsy. 1999, 53 : S38-40.
21. Hernandez-Diaz S., Werler M. M., Walker A. M., Mitchell A. A. Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects. N. Engl. J. Med., 2000, 343 (22) : 1608-1614.
22. Herzog A. G., Seibel M. M., Schomer D. L., Vaitukaitis J. L., Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch. Neurol., 1986, 43 (4) : 341-346.
23. Hiilesmaa V., Bardy A., Teramo K. Obstetric outcome in women with epilepsy. Am. J. Obstet. Gynecol., 1985, 152 (5) : 499-504.
24. Janz D. Antiepileptic drugs and pregnancy : altered utilization patterns and teratogenesis. Epilepsia, 1982, 23 Suppl 1 : S53-63.
25. Kaaja E., Kaaja R., Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology, 2003, 60 (4) : 575-9.
26. Kaaja E., Kaaja R., Matila R., Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology, 2002, 58 (4) : 549-553.
27. Kaneko S., Battino D., Andermann E., Wada K., Kan R., Takeda A., Nakane Y., Ogawa Y., Avanzini G., Fumarola C., Granata T., Molteni F., Pardi G., Minotti L., Canger R., Dansky L., Oguni M., Lopes-Cendas I., Sherwin A., Andermann E, Seni M., Okada M., Teranishi T. Congenital malformations due to antiepileptic drugs. Epilepsy Res., 1999, 33 (2-3) : 145-58.
28. Knight A., Rhind E. Epilepsy and pregnancy : a study of 153 pregnancies in 59 patients. Epilepsia, 1975, 16 (1) : 99-110.
29. Lindhout D., Meinardi H., Meijer J., Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts : changes in prescription policy paralleled by changes in pattern of malformations. Neurology, 1992, 42 (4 (Suppl 5)) : 94-110.
30. McAuley J., Anderson G. Treatment of epilepsy in women of reproductive age : pharmacokinetic considerations. Clin. Pharmacokinet., 2002, 41 (8) : 559-79.
31. Minkoff H., Schaffer R. M., Delke I., Grunebaum A. N. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet. Gynecol., 1985, 65 (3 Suppl) : 22S-24S.
32. Morrow J., Craig J. Anti-epileptic drugs in pregnancy : current safety and other issues. Expert. Opin. Pharmacother., 2003, 4 (4) : 445-56.
33. Nei M., Daly S., Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology, 1998, 51 (3) : 904-6.
34. Nelson K., Ellenberg J. Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children. Neurology, 1982, 32 (11) : 1247-1254.
35. Nulman I., Laslo D., Koren G. Treatment of epilepsy in pregnancy. Drugs, 1999, 57 (4) : 535-44.
36. Olafsson E., Hallgrimsson J., Hauser W., Ludvigsson P., Gudmundsson G. Pregnancies of women with epilepsy : a population-based study in Iceland. Epilepsia, 1998, 39 (8) : 887-92.
37. Olafsson E., Hauser W., Gudmundsson G. Fertility in patients with epilepsy : a population-based study. Neurology, 1998, 51 (1) : 71-73.
38. Ottman R., Annegers J. F., Hauser W.A., Kurland L. T. Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am. J. Hum. Genet., 1988, 43 (3) : 257-64.
39. Pennell P. B. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology, 2003, 61 (90062) : 35S-42.
40. Pennell P. B. The importance of monotherapy in pregnancy. Neurology, 2003, 60 (90114) : 31S-38.
41. Royal College of Physicians. Adults with poorly controlled epilepsy : Clinical guidelines for treatment and practical tools for aiding epilepsy management. London, 1997.
42. Sabers A., Ohman I., Christensen J., Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology, 2003, 61 (4) : 570-571.
43. Schmidt D., Canger R., Avanzini G., Battino D., Cusi C., Beck-Mannagetta G., Koch S., Rating D., Janz D. Change of seizure frequency in pregnant epileptic women. J. Neurol. Neurosurg. Psychiatry, 1983, 46 (8) : 751-755.
44. Stumpf D. A., Frost M. Seizures, anticonvulsants, and pregnancy. Am. J. Dis. Child., 1978, 132 (8) : 746-8.
45. Swartjes J., van Geijn H. Pregnancy and epilepsy. Eur. J. Obstet. Gynecol. Reprod. Biol., 1998, 79 (1) : 3-11.
46. Teramo K., Hiilesmaa V. Pregancy and fetal complication in epileptic pregnancies : review of the literature. In : Epilepsy, pregancy and the child. Janz D., Bossi L., Dam M. and et al. (eds.). New York, Raven Press, 1982.
47. Teramo K., Hiilesmaa V., Bardy A., Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J. Perinat. Med., 1979, 7 (1) : 3-6.
48. Tettenborn B., Genton P., Polson D. Epilepsy and women's issues : an update. Epileptic Disord., 2002, 4 Suppl 2: S23-31.
49. Vajda F., O'Brien T., Hitchcock A., Graham J., Lander C. The Australian registry of antiepileptic drugs in pregnancy : experience after 30 months. J. Clin. Neurosci., 2003, 10 (5) : 543-9.
50. Vigabatrin Paediatric Advisory Group. Guideline for prescribing vigabatrin in children has been revised. BMJ, 2000, 320 (7246) : 1404-.
51. Wallace H., Shorvon S., Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352 (9145) : 1970-3.
52. Yerby M. The use of anticonvulsants during pregnancy. Semin. Perinatol., 2001, 25 (3) : 153-8.
53. Yerby M. Clinical care of pregnant women with epilepsy : neural tube defects and folic acid supplementation. Epilepsia, 2003, 44 Suppl 3 : 33-40.
54. Yerby M., Cawthorn L. Mortality rates in infants of mothers with epilepsy. Ann. Neurol., 1994, 36 : 330.
55. Yerby M., Koepsell T., Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia, 1985, 26 (6) : 631-5.
56. Yerby M. S. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology, 2000, 55 (5 Suppl 1) : S21-31 ; discussion S54-8.
57. Zahn C. A., Morrell M. J., Collins S. D., Labiner D. M., Yerby M. S. Management issues for women with epilepsy : a review of the literature. Neurology, 1998, 51 (4) : 949-56.